Great! You have sucessfully subscribed for newsletters for investments
Subscribed email:
NAV as of Apr 23, 2025 | Returns since inception | ET Money Rank | VRO Ratings |
---|---|---|---|
₹308.1352+1.13% 1 day change | 16.35% p.a. | 3 |
VRO rating | 3 |
Expense ratio | 1.2% as on Mar 31, 2025 |
Exit load | 1.0% Exit load of 1% if redeemed within 30 days.! |
AUM (Fund size) | ₹1,042 Crs |
Lock-in | No Lockin |
Age | 12 yrs 3 m since Jan 01, 2013 |
Benchmark | BSE Healthcare TRI |
Min. investment | SIP ₹500 & Lump. ₹5000 |
Risk | Very High |
Short term capital gains (STCG) | Returns taxed at 20% if you redeem before 1 year |
Long term capital gains (LTCG) | After 1 year, pay tax of 12.5% on returns of ₹1.25 lakh+ in a financial year |
Period | This fund | Category average |
---|---|---|
1 month | 0.46% | 0.8% |
3 months | 0.84% | 0.61% |
6 months | -1.34% | -1.43% |
1 year | 24.65% | 21.96% |
3 years | 22.24% | 22.2% |
5 years | 23.38% | 23.82% |
7 years | 19.14% | 20.19% |
10 years | 12.44% | 13.65% |
Large Cap 28.880031%
Mid Cap 27.758957999999996%
Small Cap 42.57101099999999%
Other Cap 0.0%
Healthcare 99.20000000000002%
Bifurcation by Credit Quality is not available for this fund
Others 0.01%
Net Current Assets 0.78113236%
CBLO 0.0134352%
Others 0.78%
Fund name | ETM Rank | AUM (in Crs.) | Fund age | Expense ratio |
---|---|---|---|---|
UTI Healthcare Fund | N.A. | ₹1,042 Crs | 12 yrs 3 m | 1.2% |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | N.A. | ₹4,915 Crs | 6 yrs 9 m | 1.18% |
SBI Healthcare Opportunities Fund | N.A. | ₹3,611 Crs | 12 yrs 3 m | 0.9% |
DSP Healthcare Fund | N.A. | ₹3,019 Crs | 6 yrs 5 m | 0.63% |
Tata India Pharma & HealthCare Fund | N.A. | ₹1,184 Crs | 9 yrs 4 m | 0.72% |
Mirae Asset Healthcare Fund | N.A. | ₹2,667 Crs | 6 yrs 10 m | 0.61% |
Fund name | 1M | 6M | 1Y | 3Y | 5Y | 10Y |
---|---|---|---|---|---|---|
UTI Healthcare Fund | 0.46% | -1.34% | 24.65% | 22.24% | 23.38% | 12.44% |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | 1.25% | -0.91% | 25.04% | 25.89% | 26.38% | 15.1% |
SBI Healthcare Opportunities Fund | 0.06% | 2.93% | 23.15% | 25.24% | 25.94% | 13.32% |
DSP Healthcare Fund | -1.44% | -5.28% | 18.69% | 22.05% | 26.08% | 15.24% |
Tata India Pharma & HealthCare Fund | 1.88% | -1.7% | 21.43% | 22.65% | 23.83% | 13.09% |
Mirae Asset Healthcare Fund | 0.52% | -1.7% | 22.46% | 20.85% | 24.59% | 15.25% |
Fund name | Std. deviation | Beta | Sharpe | Sortino |
---|---|---|---|---|
UTI Healthcare Fund | 16.7 | 0.95 | 0.85 | 1.35 |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | 16.26 | 0.93 | 1.01 | 1.61 |
SBI Healthcare Opportunities Fund | 14.93 | 0.85 | 1.12 | 1.65 |
DSP Healthcare Fund | 15.95 | 0.87 | 0.91 | 1.56 |
Tata India Pharma & HealthCare Fund | 16.85 | 0.96 | 0.82 | 1.36 |
Mirae Asset Healthcare Fund | 17.14 | 0.98 | 0.77 | 1.27 |
Alpha | 0.99 vs. 3.94 Underperformed at beating benchmark |
Sharpe | 0.85 vs. 4.28 Poor risk-adjusted returns |
Beta | 0.95 vs. 0.75 More sensitive to market's ups & downs |
Standard deviation | 16.7 vs. 10.22 More volatile performance |
Fund AUM | ₹1,042 Crs as on Mar 31, 2025 |
Scheme document | View Scheme Document |
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
No. of schemes | 62 view all schemes |
Total AUM | ₹3,39,983 Crs as on Mar 31, 2025 |
Address | UTI Tower, Plot C-1, GN Block, Banrda Kurla Complex, Bandra (East) Mumbai, 400051 |
Phone | 0263 2296993 |
Fund name | ETM Rank | AUM (in Crs.) | 1Y | 5Y |
---|---|---|---|---|
UTI Transportation and Logistics Fund | N.A. | ₹3,163 Crs | 2.91% | 32.66% |
UTI Large & Mid Cap Fund | N.A. | ₹4,101 Crs | 15.03% | 30.99% |
UTI Mid Cap Fund | N.A. | ₹10,649 Crs | 8.34% | 29.21% |
UTI Infrastructure Fund | N.A. | ₹2,097 Crs | 4.9% | 28.6% |
UTI Value Fund | N.A. | ₹9,455 Crs | 15.82% | 26.98% |
UTI Banking and Financial Services Fund | N.A. | ₹1,211 Crs | 19.97% | 26.71% |
The current Net Asset Value (NAV) of the UTI Healthcare Fund - Direct Growth plan is approximately ₹308.1352 as of Apr 23, 2025.
The UTI Healthcare Fund is a 12 yrs 3 m old fund and has delivered average annual returns of 16.35% since inception.
1-Year | 3-Year | 5-Year | 10-Year | Since Inception |
---|---|---|---|---|
24.65% | 22.24% | 23.38% | 12.44% | 16.35% |
The UTI Healthcare Fund - Direct Growth has an expense ratio of 1.2%, which reflects the fund's management and operating costs. This percentage is subtracted from the fund's annual returns, impacting net returns for investors.
The UTI Healthcare Fund currently has assets under management (AUM) or fund size valued at approximately ₹1,042 Crs crore as of Mar 31, 2025.
The UTI Healthcare Fund has invested the majority of its money in the stocks of the following companies -
Company | Percentage of Portfolio |
---|---|
Sun Pharmaceutical Industries Ltd. | 11.65% |
Cipla Ltd. | 5.81% |
Ajanta Pharma Ltd. | 4.4% |
Dr. Reddy's Laboratories Ltd. | 4.35% |
Glenmark Pharmaceuticals Ltd. | 4.07% |
Procter & Gamble Health Ltd. | 3.65% |
Apollo Hospitals Enterprise Ltd. | 3.57% |
Fortis Healthcare Ltd. | 3.12% |
Divi's Laboratories Ltd. | 3.1% |
Alkem Laboratories Ltd. | 2.99% |
The UTI Healthcare Fund has primarily invested in the following sectors
Sector | Percentage of Portfolio |
---|---|
Healthcare | 99.20000000000002% |
This is a Sectoral-pharma fund comes with Very High risk.
No, this fund does not have any lock-in period.
It is very fast, easy, and completely paperless in this mutual fund scheme on ET Money. It is just a matter of a few minutes. Here's how:
For the Desktop Version:
For the Mobile Version:
All set! Your investment in UTI Healthcare Fund is complete.
Redeeming your investments in UTI Healthcare Fund is super easy. If you have invested in this fund via ET Money, just login into the app, go to the investment section and put the redemption request.
If you have invested in UTI Healthcare Fund from anywhere else, you can go to the fund house website and put a request through it.